Orange Book product · Brand (NDA)
TRILAFON
PERPHENAZINE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
PERPHENAZINE
Strength
8MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
Not listed
Application
NDA 011361
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- —TRILAFONBrand (NDA)
NDA 011557 · SCHERING
- —TRILAFONBrand (NDA)
NDA 011213 · SCHERING
- —TRILAFONBrand (NDA)
NDA 011294 · SCHERING
- —TRILAFONBrand (NDA)
NDA 010775 · SCHERING
- 2025PERPHENAZINEGeneric (ANDA)
ANDA 213694 · JUBILANT GENERICS
- 2024PERPHENAZINEGeneric (ANDA)
ANDA 212545 · MACLEODS PHARMS LTD
- 2022PERPHENAZINEGeneric (ANDA)
ANDA 210163 · APPCO
- 2020PERPHENAZINEGeneric (ANDA)
ANDA 205232 · ZYDUS PHARMS
- 2019PERPHENAZINEGeneric (ANDA)
ANDA 205056 · RISING
- 2017PERPHENAZINEGeneric (ANDA)
ANDA 206691 · MYLAN
- 2016PERPHENAZINEGeneric (ANDA)
ANDA 207582 · WATSON LABS INC
- 2015PERPHENAZINEGeneric (ANDA)
ANDA 205973 · WILSHIRE PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
